Quantum-Si, Inc. is a pharmaceutical company based in the United States. With a low risk rating score of 18.7, Quantum-Si is dedicated to transforming proteomics with innovative technologies. Their semiconductor chip is at the forefront of single-molecule protein sequencing and genomics, digitizing research to propel drug development and diagnostics. Explore Quantum-Si for groundbreaking advancements in ESG-focused healthcare solutions.